Literature DB >> 15767508

Clinical implications of splenium magnetic resonance imaging signal changes.

Michael J Doherty1, Sumie Jayadev, Nathaniel F Watson, Ravi S Konchada, Dan K Hallam.   

Abstract

BACKGROUND: Magnetic resonance imaging (MRI) may show discrete splenium abnormalities; however, the implications of this radiologic finding are unclear.
OBJECTIVE: To describe causes, clinical presentations, and prognoses of midline splenium changes evident on MRI.
DESIGN: Retrospective case series.
SETTING: Teaching hospital. PATIENTS: Medical records of 9 patients with MRI-noted splenium changes were studied; 60 additional published cases were accessed.
INTERVENTIONS: Sixty-nine cases were reviewed. MAIN OUTCOME MEASURES: Clinical and imaging findings, causes, and prognosis.
RESULTS: Confusion (35 patients), ataxia (25 patients), and recent seizure (23 patients) were common. Causes included alcohol use, infections, hypoglycemia, trauma, salt abnormalities, and seizure. Twenty-eight patients had complete resolution, 23 improved, and 1 died. Diffusion-weighted imaging showed splenium abnormalities the best. Eleven of 12 patients showed decrease in apparent diffusion coefficient. Most improved clinically, as did their subsequent MRI studies.
CONCLUSIONS: Midline splenium changes are commonly seen on MRI diffusion-weighted imaging sequences. Multiple causes can result in splenium changes. Physicians should evaluate for glucose and electrolyte abnormalities, seizure risk, ongoing infectious or parainfectious process, and traumatic causes.

Entities:  

Mesh:

Year:  2005        PMID: 15767508     DOI: 10.1001/archneur.62.3.433

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  42 in total

1.  Focal transient lesion in the splenium of the corpus callosum in three non-epileptic patients.

Authors:  Antônio José da Rocha; Fabiano Reis; Hugo Pereira Pinto Gama; Carlos Jorge da Silva; Flávio Túlio Braga; Antônio Carlos Martins Maia; Fernando Cendes
Journal:  Neuroradiology       Date:  2006-08-30       Impact factor: 2.804

2.  Diffuse lesion in the splenium of the corpus callosum in patients with methyl bromide poisoning.

Authors:  K Kang; Y-M Song; K D Jo; J-K Roh
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-05       Impact factor: 10.154

3.  Rapid improvement of diffusion-weighted imaging abnormalities after glucose infusion in hypoglycaemic coma.

Authors:  J Maruya; H Endoh; H Watanabe; H Motoyama; H Abe
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01       Impact factor: 10.154

Review 4.  [Corpus callosum. Landmark of the origin of cerebral diseases].

Authors:  E Hattingen; M Nichtweiss; S Blasel; F E Zanella; S Weidauer
Journal:  Radiologe       Date:  2010-02       Impact factor: 0.635

5.  Vanishing splenial lesion presenting as alexia with dysgraphia.

Authors:  Rajendra Singh Jain; Sunil Kumar; Madhuparna Paul; Rakesh Agrawal
Journal:  J Neurol       Date:  2015-02-17       Impact factor: 4.849

6.  Etiology of Corpus Callosum Lesions with Restricted Diffusion.

Authors:  C A Wilson; M T Mullen; B P Jackson; K Ishida; S R Messé
Journal:  Clin Neuroradiol       Date:  2015-06-02       Impact factor: 3.649

7.  Comparison of neuropsychiatric symptoms and diffusion tensor imaging correlates among patients with subcortical ischemic vascular disease and Alzheimer's disease.

Authors:  Min-Chien Tu; Wen-Hui Huang; Yen-Hsuan Hsu; Chung-Ping Lo; Jie Fu Deng; Ching-Feng Huang
Journal:  BMC Neurol       Date:  2017-07-28       Impact factor: 2.474

8.  Reversible pancallosal signal changes in febrile encephalopathy: report of 2 cases.

Authors:  S E Sreedharan; J Chellenton; M P Kate; C Kesavadas
Journal:  AJNR Am J Neuroradiol       Date:  2011-01-13       Impact factor: 3.825

9.  Progressive Wallerian Degeneration of the Corpus Callosal Splenium in a Patient with Alexia Without Agraphia: Advanced MR Findings.

Authors:  Kriti Gandhi; Laura Gillihan; Marcella A Wozniak; Jiachen Zhuo; Prashant Raghavan
Journal:  Neuroradiol J       Date:  2014-12-01

10.  Association of reversible splenial lesion syndrome (RESLES) with Anti-VGKC autoantibody syndrome: a case report.

Authors:  Thomas R Gilder; Jason S Hawley; Brett J Theeler
Journal:  Neurol Sci       Date:  2016-01-07       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.